Skip to main content Skip to main menu
UF Health University of Florida
Department of Pharmacology & Therapeutics College of Medicine
Donate
May Khanna

May Khanna, Ph.D.

Associate Professor & Assistant Dean of Innovation and Entrepreneurship

Department: MD-PHARMACOLOGY – THERAPEUTICS
Business Email: may.khanna@ufl.edu

On This Page

Teaching Profile

Courses Taught

  1. GMS6009 – Principles of Drug Action and Therapeutics

    College of Medicine

  2. GMS6847 – Translational Research and Therapeutics: Bench, Bedside, Community, & Policy

    College of Medicine

Research Profile

May Khanna is an Associate Professor in the Department of Pharmacology & Therapeutics, with expertise in small molecule therapeutics for neurodegenerative diseases, including ALS, Alzheimer’s, and Batten disease. Her research lab is dedicated to the development of preclinical small molecule drugs for these diseases, bridging academia and industry to accelerate drug discovery. She is committed to mentoring the next generation of scientists and supporting innovative approaches in academic research. She is also the inaugural Assistant Dean for Entrepreneurship and Innovation at the University of Florida College of Medicine, where she focuses on fostering an entrepreneurial culture among academic scientists.

Publications

Academic Articles

  1. Identifying interactions between TDP-43’s N-terminal and RNA-binding domains.

    Journal
    Protein science : a publication of the Protein Society.
    Volume/Issue
    34(10)
    [DOI]
    10.1002/pro.70295.
    [PMID]
    40960392.
    PubMed Publisher’s Site

Grants

  1. Novel Involvement of eNAMPT/TLR4 Signaling in PAH Vascular Remodeling and Right Ventricular Dysfunction

    Active

    Role:
    Co-Investigator
    Funding:
    NATL INST OF HLTH NHLBI

  2. Biophysical and pathophysiological studies of TDP-43/Tau interaction

    Active

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NINDS

  3. Development of of Heterobifunctional Degraders of TDP-43 as a Novel Therapeutic Strategy for Amyotrophic Lateral Sclerosis (ALS)

    Active

    Role:
    Principal Investigator
    Funding:
    US ARMY MED RES ACQUISITION

  4. Targeting CLN3 mRNA for Innovative Batten Disease Therapeutics: Combining Structural Probing and Molecular Docking for Small Molecule Discovery

    Active

    Role:
    Principal Investigator
    Funding:
    FOREBATTEN FOUNDATION

  5. Development of Novel Blood-Brain Barrier Impenetrable GABA Transaminase Inhibitors to Treat Hyperglycemia, Hyperinsulinemia, and Insulin Resistance

    Active

    Role:
    Principal Investigator
    Funding:
    UNIVERSITY OF ARIZONA via US ARMY MED RES ACQUISITION

Contact Details

Emails:
Business:
may.khanna@ufl.edu
Addresses:
Business Street:
PO Box 100267
 GAINESVILLE FL 32610